Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-02

Clinical Trial Update: An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct

View source ↗

Summary

An observational study assessing joint health in people with Hemophilia A taking Esperoct, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esperoct (turoctocog alfa pegol)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Haemophilia A | Status: RECRUITING